Mira Pharmaceuticals Inc Ordinary Shares MIRA 深 滬
等待開盤 09-25 09:30:00 美东时间
1.35
+0.050
+3.85%
華盛通- 最 高1.37
- 今 開1.31
- 成交量 31.69万股
- 最 低 1.29
- 昨 收 1.30
- 總市值 2284.15万
- 52周最高 2.56
- 市盈率 靜 --
- 換手率 1.87%
- 52周最低 0.73
- 委 比 -90.12%
- 總股本 1691.96万
- 歷史最高 7.9799
- 量 比 0.69
- 振 幅 6.15%
- 歷史最低 0.51
- 每 手 1
- 風險率 0.24%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多MIRA Pharmaceuticals Reports Positive Ketamir-2 Study Results
An update from MIRA Pharmaceuticals, Inc. ( ($MIRA) ) is now available. MIRA Ph...
09-16 04:39
MIRA Pharmaceutical shares are trading lower after the company announced that it approved the acquisition of SKNY Pharmaceuticals
MIRA Pharmaceutical shares are trading lower after the company announced that i...
09-12 23:43
MIRA Pharmaceuticals Approves 2022 Omnibus Incentive Plan
MIRA Pharmaceuticals, Inc. ( ($MIRA) ) has shared an announcement. On September...
09-12 05:48
零跑Lafa 5/深蓝S05领衔 2025慕尼黑车展中国品牌新车前瞻
作为全球汽车行业瞩目的盛会，2025慕尼黑车展（IAA2025）将于9月8日至14日举行，本届车展吸引众多车企亮相重磅新车。除了海外新车值得关注外，不少中国...
09-05 10:00
AbbVie's Elahere gains approval in Canada for ovarian cancer
Health Canada has approved AbbVie's (NYSE:ABBV) antibody-drug conjugate Elahere (mirvetuximab soravtansine) for ovarian cancer. The treatment is approved for women who have received one to three othe...
09-03 02:01
Abbvie Secures Health Canada Approval For ELAHERE Under Priority Review To Treat FRα+ Platinum-Resistant Ovarian And Related Cancers
Health Canada has approved ELAHERE®, the first novel therapy to demonstrate statistically significant and clinically meaningful improvements in overall survival (OS) compared to chemotherapy alone for patients with
09-03 00:46
Mira Pharmaceuticals Q2 EPS $(0.09) Beats $(0.13) Estimate
Mira Pharmaceuticals (NASDAQ:MIRA) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.13) by 30.77 percent. This is a 18.18 percent increase over losses of $(0.11) per share
08-15 04:55
MIRA Pharmaceuticals Reports Promising Preclinical Results
MIRA Pharmaceuticals, Inc. ( ($MIRA) ) has provided an announcement. On July 29...
07-30 04:43
